Company Active LTD

Company profile

Biomavericks Ltd

BioMavericks

Biomavericks Ltd is a UK company with status active founded in 2021.

CRN
13439245
Founded
2021
Age
5

Overview

Legal name
BIOMAVERICKS LTD
Region
Unknown
Registered address
INTERNATIONAL HOUSE
64 NILE STREET
LONDON
UNITED KINGDOM
N1 7SR
Insolvency history
No

Latest accounts

Financial period: 1 Jul 2023 to 30 Jun 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
2

Company events

Reference milestones and recent Companies House filing stream events.

6 events
31 Mar
2027

Accounts due

Accounts Due

Next accounts due date

23 Jun
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

19 Jun
2026

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzUyNzM2MDI1NmFkaXF6a2N4

Published 19 Jun 2026 15:09

30 Jun
2025

Accounts filed

Accounts

Last accounts made up date

09 Jun
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

04 Jun
2021

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2022
Funded years
2022, 2023
Age at first award
1 years

Projects

2023 Investment Accelerator Lead participant

Performance Evaluation of a PCR Test Targeting Novel Leukocyte Biomarkers for Early Detection of Pancreatic Cancer: A Pilot Study

1 Dec 2023 to 30 Nov 2024

Awarded
£50,000
Total cost £50,000

Pancreatic cancer remains a significant health concern with a poor prognosis, largely due to limitations in early diagnostics. Current methods, often dependent on detecting tumour-derived components, offer inadequate sensitivity and specificity. Our project seeks to radically transform this grim landscape by introducing a game-changing diagnostic method t...

2022 Grant for R&D Lead participant

Developing profiles for early pancreatic cancer through bioinformatics analysis

1 Nov 2022 to 30 Apr 2023

Awarded
£50,000
Total cost £50,000

Pancreatic cancer is the 5th leading cause of cancer-related death in the UK. Statistics have shown that the five-year survival rate will be markedly increased from 3% to 39% if tumours can be detected at early stages (Cancer Facts & Figures, 2021). However, due to the lack of validated and specific screening tests for early-stage pancreatic cancer patien...

Product types

Grant for R&D Investment Accelerator